Healthcare provider profile · identity verified

Timothy R Rasmussen, MD

Psychiatry · WAITE PARK, MN · NPI 1144293937

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Bupropion Xl	Bupropion Hcl	385	35
Clonazepam	Clonazepam	358	44
Escitalopram Oxalate	Escitalopram Oxalate	298	32
Alprazolam	Alprazolam	282	43
Lorazepam	Lorazepam	265	35
Mirtazapine	Mirtazapine	260	30
Quetiapine Fumarate	Quetiapine Fumarate	256	20
Venlafaxine Hcl Er	Venlafaxine Hcl	252	22
Topiramate	Topiramate	250	22
Olanzapine	Olanzapine	240	22
Risperidone	Risperidone	220	19
Duloxetine Hcl	Duloxetine Hcl	212	22
Trazodone Hcl	Trazodone Hcl	205	25
Sertraline Hcl	Sertraline Hcl	202	18
Lamotrigine	Lamotrigine	197	22
Aripiprazole	Aripiprazole	190	22
Benztropine Mesylate	Benztropine Mesylate	152	14
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	140	13
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	139	12
Fluoxetine Hcl	Fluoxetine Hcl	131	15
Clozapine	Clozapine	116	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	114	suppressed
Gabapentin	Gabapentin	107	suppressed
Fetzima	Levomilnacipran Hcl	104	suppressed
Citalopram Hbr	Citalopram Hydrobromide	102	15
Eszopiclone	Eszopiclone	102	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	98	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	94	suppressed
Divalproex Sodium Er	Divalproex Sodium	87	suppressed
Buspirone Hcl	Buspirone Hcl	75	11
Trintellix	Vortioxetine Hydrobromide	75	suppressed
Methylphenidate Er	Methylphenidate Hcl	74	suppressed
Paroxetine Hcl	Paroxetine Hcl	72	suppressed
Temazepam	Temazepam	71	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	69	suppressed
Vraylar	Cariprazine Hcl	68	suppressed
Diazepam	Diazepam	62	suppressed
Prazosin Hcl	Prazosin Hcl	57	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	55	suppressed
Oxcarbazepine	Oxcarbazepine	53	suppressed
Rexulti	Brexpiprazole	53	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	53	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	43	suppressed
Paliperidone Er	Paliperidone	39	suppressed
Lithium Carbonate	Lithium Carbonate	38	suppressed
Loxapine	Loxapine Succinate	38	suppressed
Zaleplon	Zaleplon	38	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	suppressed
Lurasidone Hcl	Lurasidone Hcl	34	suppressed
Triazolam	Triazolam	34	suppressed
Clomipramine Hcl	Clomipramine Hcl	29	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	29	suppressed
Vilazodone Hcl	Vilazodone Hcl	29	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	29	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	28	suppressed
Carbamazepine	Carbamazepine	26	suppressed
Divalproex Sodium	Divalproex Sodium	26	suppressed
Doxepin Hcl	Doxepin Hcl	26	suppressed
Haloperidol	Haloperidol	24	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	24	suppressed
Modafinil	Modafinil	24	suppressed
Wellbutrin Xl	Bupropion Hcl	24	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	23	suppressed
Effexor Xr	Venlafaxine Hcl	21	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Dayvigo	Lemborexant	19	suppressed
Trifluoperazine Hcl	Trifluoperazine Hcl	19	suppressed
Paroxetine Er	Paroxetine Hcl	17	suppressed
Belsomra	Suvorexant	16	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Ramelteon	Ramelteon	14	suppressed
Armodafinil	Armodafinil	13	suppressed
Clozaril	Clozapine	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Invega Sustenna	Paliperidone Palmitate	13	suppressed
Lexapro	Escitalopram Oxalate	13	suppressed
Zoloft	Sertraline Hcl	13	suppressed
Caplyta	Lumateperone Tosylate	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Paroxetine Cr	Paroxetine Hcl	12	suppressed
Zyprexa	Olanzapine	12	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	11	suppressed
Concerta	Methylphenidate Hcl	11	suppressed
Geodon	Ziprasidone Hcl	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Methylphenidate Er (La)	Methylphenidate Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error